Mark D Okusa

Title: Innovations of Mark D Okusa in Autoimmune and Inflammatory Disease Treatment

Introduction

Mark D Okusa is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune and inflammatory diseases. With a total of 8 patents to his name, Okusa's work focuses on innovative therapies that leverage the properties of interleukins.

Latest Patents

Okusa's latest patents include compositions and methods for the treatment of autoimmune and inflammatory diseases and disorders. One notable invention is a novel fusion peptide of IL-2 and IL-33. This invention comprises a biologically active domain of Interleukin-2 (IL-2) and a biologically active domain of Interleukin-33 (IL-33). The two portions can be linked by a linker sequence. The application reveals that combination therapies using IL-2 and IL-33, or therapies using the IL233 fusion protein, are effective in preventing or treating various diseases and disorders, including autoimmune diseases and inflammation. Depending on the subject's condition, these compositions can be useful for preventing symptoms, treating the disease, and alleviating some symptoms.

Career Highlights

Throughout his career, Okusa has worked with esteemed institutions, including the University of Virginia. His research has significantly advanced the understanding and treatment of complex medical conditions.

Collaborations

Okusa has collaborated with notable colleagues such as Timothy L MacDonald and Joel M Linden. Their combined expertise has contributed to the development of innovative therapeutic approaches.

Conclusion

Mark D Okusa's work exemplifies the impact of innovative research in the medical field. His patents and collaborations continue to pave the way for advancements in the treatment of autoimmune and inflammatory diseases.